4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0002034668-25-000007
Chief Financial Officer sold 6,415 shares at $18.23 ($116,931)
- Chief Financial Officer acquired 6,415 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hyep Ivan Chief Financial Officer | 2025-10-09 | Option exercise 10b5-1 | +6,415 | $3.79 | $24,312 | 151,770 | D |
| Hyep Ivan Chief Financial Officer | 2025-10-09 | Sale 10b5-1 | −6,415 | $18.23 | $116,931 | 145,355 | D |
| Derivatives | |||||||
| Hyep Ivan Chief Financial Officer | 2025-10-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,415 | 116,584 | D | ||
| Open-market sales · 6,415 sh · avg $18.23 · $116,931 | |||||||
Loading xslF345X05/wk-form4_1760131373.xml…